These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 8454255)

  • 21. Atrial fibrillation: drug therapies for ventricular rate control and restoration of sinus rhythm.
    Chandramouli BV; Kotler MN
    Geriatrics; 1998 Jun; 53(6):46-8, 51-2, 54, 57-60. PubMed ID: 9634106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiarrhythmic drugs in paroxysmal atrial fibrillation. When and how?].
    Lévy S; Ricard P; Yapo F; Mansouri C
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():19-24. PubMed ID: 8734159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
    Cosío FG
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):677; author reply 677. PubMed ID: 15946374
    [No Abstract]   [Full Text] [Related]  

  • 28. Spatial extension of local pacing capture in the lateral free wall of the right atrium during clinical chronic atrial fibrillation.
    Pandozi C; Villani M; Castro A; Altamura G; Gentilucci G; Scianaro MC; Ammirati F; Magris B; Jesi AP; Santini M
    G Ital Cardiol; 1999 Feb; 29(2):107-14. PubMed ID: 10088065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug therapy of atrial fibrillation].
    Fazekas T; Csanádi Z; Varró A
    Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
    López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
    Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation.
    Andrews M; Nelson BP
    Mt Sinai J Med; 2006 Jan; 73(1):482-92. PubMed ID: 16470327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial structural remodeling as an antiarrhythmic target.
    Burstein B; Nattel S
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of atrial fibrillation, what to know on old and new antiarrhythmics].
    Le Heuzey JY
    Ann Cardiol Angeiol (Paris); 2010 Dec; 59 Suppl 1():S24-7. PubMed ID: 21211622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New directions in antiarrhythmic drug therapy for atrial fibrillation.
    Heijman J; Voigt N; Dobrev D
    Future Cardiol; 2013 Jan; 9(1):71-88. PubMed ID: 23259476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 38. Electrophysiologic approach to atrial fibrillation.
    Cotoi S; Georgescu C
    Med Interne; 1979; 17(4):371-8. PubMed ID: 515662
    [No Abstract]   [Full Text] [Related]  

  • 39. Do non-antiarrhythmic drugs have enough pleiotropic power to reduce atrial fibrillation?
    Folkeringa RJ; Crijns HJ
    Europace; 2010 Mar; 12(3):299-300. PubMed ID: 20173204
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.